标题
Targeted Therapy for Colorectal Cancer
作者
关键词
Metastatic colorectal cancer, Targeted therapy, Bevacizumab, EGFR
出版物
Surgical Oncology Clinics of North America
Volume 31, Issue 2, Pages 255-264
出版商
Elsevier BV
发表日期
2022-03-10
DOI
10.1016/j.soc.2021.11.006
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Evolutionary Landscape of Treatment for BRAFV600E Mutant Metastatic Colorectal Cancer
- (2021) Gianluca Mauri et al. Cancers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Diagnosis and Treatment of Metastatic Colorectal Cancer
- (2021) Leah H. Biller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
- (2021) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines
- (2021) A. Grothey et al. ANNALS OF ONCOLOGY
- Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes
- (2021) Joseph C. Kong et al. ANNALS OF SURGICAL ONCOLOGY
- Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation
- (2021) Zaina T. Al-Salama DRUGS
- Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group
- (2020) T. André et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Spotlight: US Multi-Society Task Force on Colorectal Cancer Recommendations for Follow-up After Colonoscopy and Polypectomy
- (2020) Samir Gupta et al. GASTROENTEROLOGY
- Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial
- (2020) John A Bridgewater et al. LANCET ONCOLOGY
- Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer
- (2020) Eleonora Lai et al. Cancers
- Molecular Insights Into Colorectal Carcinoma
- (2020) Domenika Ortiz Requena et al. ARCHIVES OF MEDICAL RESEARCH
- Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
- (2020) Thierry André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
- (2019) Funda Meric-Bernstam et al. LANCET ONCOLOGY
- Chemotherapy With or Without Anti-EGFR Agents in Left- and Right-Sided Metastatic Colorectal Cancer: An Updated Meta-Analysis
- (2019) Zi-Xian Wang et al. Journal of the National Comprehensive Cancer Network
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
- (2019) Scott Kopetz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colorectal cancer
- (2019) Evelien Dekker et al. LANCET
- The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Saeid Safiri et al. Lancet Gastroenterology & Hepatology
- A Curative‐Intent Trimodality Approach for Isolated Abdominal Nodal Metastases in Metastatic Colorectal Cancer: Update of a Single‐Institutional Experience
- (2018) Benny Johnson et al. ONCOLOGIST
- Outcome of Mismatch Repair‐Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience
- (2018) Zhaohui Jin et al. ONCOLOGIST
- The Future of Rectal Cancer Surgery: A Narrative Review of an International Symposium
- (2018) F. Borja de Lacy et al. Surgical Innovation
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials
- (2017) Julian Walter Holch et al. EUROPEAN JOURNAL OF CANCER
- Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer
- (2017) Douglas K. Rex et al. GASTROENTEROLOGY
- Molecular Markers for Colorectal Cancer
- (2017) Moriah Wright et al. SURGICAL CLINICS OF NORTH AMERICA
- How Should Imaging Direct/Orient Management of Rectal Cancer?
- (2017) Jemma Bhoday et al. Clinics in Colon and Rectal Surgery
- Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study
- (2017) Nikol Snoeren et al. NEOPLASIA
- Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer
- (2016) Charles J. Kahi et al. GASTROENTEROLOGY
- Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
- (2016) Andrea Sartore-Bianchi et al. LANCET ONCOLOGY
- Role of First-Line Anti–Epidermal Growth Factor Receptor Therapy Compared With Anti–Vascular Endothelial Growth Factor Therapy in Advanced Colorectal Cancer: A Meta-Analysis of Randomized Clinical Trials
- (2015) Muhammad A. Khattak et al. Clinical Colorectal Cancer
- Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment andRASMutations in Colorectal Cancer
- (2015) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment
- (2015) S. M. Kavuri et al. Cancer Discovery
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
- (2012) Aimery de Gramont et al. LANCET ONCOLOGY
- Young-Onset Rectal Cancer: Presentation, Pattern of Care and Long-term Oncologic Outcomes Compared to a Matched Older-Onset Cohort
- (2011) Y. Nancy You et al. ANNALS OF SURGICAL ONCOLOGY
- BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome
- (2010) Z Saridaki et al. BRITISH JOURNAL OF CANCER
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- (2010) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
- (2010) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now